Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Gregory Y H Lip; Julius Nikorowitsch; Susanne Sehner; Nina Becher; Emanuele Bertaglia; Carina Blomstrom-Lundqvist; Axel Brandes; Vincent Beuger; Melanie Calvert; A John Camm; Gregory Chlouverakis; Gheorghe-Andrei Dan; Wolfgang Dichtl; Hans Christoph Diener; Alexander Fierenz; Andreas Goette; Joris R de Groot; Astrid Hermans; Andrzej Lubinski; Eloi Marijon; Béla Merkely; Lluís Mont; Ann-Kathrin Ozga; Kim Rajappan; Andrea Sarkozy; Daniel Scherr; Renate B Schnabel; Ulrich Schotten; Emmanuel Simantirakis; Tobias Toennis; Panos Vardas; Dan Wichterle; Antonia Zapf; Paulus Kirchhof

doi:10.1093/eurheartj/ehae225

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Gregory Y H Lip
, Julius Nikorowitsch
, Susanne Sehner
, Nina Becher
, Emanuele Bertaglia
, Carina Blomstrom-Lundqvist
, Axel Brandes
, Vincent Beuger
, Melanie Calvert
, A John Camm
, Gregory Chlouverakis
, Gheorghe-Andrei Dan
, Wolfgang Dichtl
, Hans Christoph Diener
, Alexander Fierenz
, Andreas Goette
, Joris R de Groot
, Astrid Hermans
, Andrzej Lubinski
, Eloi Marijon

Béla Merkely, Lluís Mont, Ann-Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Daniel Scherr, Renate B Schnabel, Ulrich Schotten, Emmanuel Simantirakis, Tobias Toennis, Panos Vardas, Dan Wichterle, Antonia Zapf, Paulus Kirchhof

Liverpool Centre for Cardiovascular Science at University of Liverpool
Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany
University Medical Centre-Hamburg-Eppendorf
Cardiology Unit Camposampiero Hospital - AULSS Euganea Padua Italy
Uppsala University
University of Southern Denmark
Atrial Fibrillation Network (AFNET)
University of Birmingham
University of London
University of Crete
Colentina University Hospital
Innsbruck Medical University
University of Duisburg-Essen, Duisburg-Essen, Germany
St Vincenz-Hospital Paderborn
Maastricht University
Medical University of Gdańsk
Gastroenterology and Digestive Oncology Department, European Hospital, Georges Pompidou, 75015 Paris, France. [email protected].
Semmelweis University
University Clinic Hospital
Oxford University Hospitals NHS Foundation Trust
Antwerp University Hospital
Medical University of Graz
Heraklion University Hospital
Institute for Clinical and Experimental Medicine

Research output: Contribution to journal › Article › Academic › peer-review

14 Downloads (Pure)

Original language	English
Pages (from-to)	1733-1737
Number of pages	5
Journal	European heart journal
Volume	45
Issue number	19
DOIs	https://doi.org/10.1093/eurheartj/ehae225
Publication status	Published - 21 May 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Humans
Atrial Fibrillation/drug therapy
Anticoagulants/administration & dosage
Female
Male
Administration, Oral
Age Factors
Aged
Sex Factors
Stroke/prevention & control
Comorbidity
Treatment Outcome
Cardiovascular Diseases/prevention & control

Access to Document

10.1093/eurheartj/ehae225

Oral-anticoagulation-in-device-detected-atrial-fibrillation.pdfFinal published version, 2.2 MBLicence: Taverne

Cite this

Lip, G. Y. H., Nikorowitsch, J., Sehner, S., Becher, N., Bertaglia, E., Blomstrom-Lundqvist, C., Brandes, A., Beuger, V., Calvert, M., Camm, A. J., Chlouverakis, G., Dan, G.-A., Dichtl, W., Diener, H. C., Fierenz, A., Goette, A., de Groot, J. R., Hermans, A., Lubinski, A., ... Kirchhof, P. (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. European heart journal, 45(19), 1733-1737. https://doi.org/10.1093/eurheartj/ehae225

@article{3a6f4b3035f8405cac935d97f2ed2fad,

title = "Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial",

keywords = "Humans, Atrial Fibrillation/drug therapy, Anticoagulants/administration \& dosage, Female, Male, Administration, Oral, Age Factors, Aged, Sex Factors, Stroke/prevention \& control, Comorbidity, Treatment Outcome, Cardiovascular Diseases/prevention \& control",

author = "Lip, \{Gregory Y H\} and Julius Nikorowitsch and Susanne Sehner and Nina Becher and Emanuele Bertaglia and Carina Blomstrom-Lundqvist and Axel Brandes and Vincent Beuger and Melanie Calvert and Camm, \{A John\} and Gregory Chlouverakis and Gheorghe-Andrei Dan and Wolfgang Dichtl and Diener, \{Hans Christoph\} and Alexander Fierenz and Andreas Goette and \{de Groot\}, \{Joris R\} and Astrid Hermans and Andrzej Lubinski and Eloi Marijon and B{\'e}la Merkely and Llu{\'i}s Mont and Ann-Kathrin Ozga and Kim Rajappan and Andrea Sarkozy and Daniel Scherr and Schnabel, \{Renate B\} and Ulrich Schotten and Emmanuel Simantirakis and Tobias Toennis and Panos Vardas and Dan Wichterle and Antonia Zapf and Paulus Kirchhof",

year = "2024",

month = may,

day = "21",

doi = "10.1093/eurheartj/ehae225",

language = "English",

volume = "45",

pages = "1733--1737",

journal = "European heart journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "19",

}

Lip, GYH, Nikorowitsch, J, Sehner, S, Becher, N, Bertaglia, E, Blomstrom-Lundqvist, C, Brandes, A, Beuger, V, Calvert, M, Camm, AJ, Chlouverakis, G, Dan, G-A, Dichtl, W, Diener, HC, Fierenz, A, Goette, A, de Groot, JR, Hermans, A, Lubinski, A, Marijon, E, Merkely, B, Mont, L, Ozga, A-K, Rajappan, K, Sarkozy, A, Scherr, D, Schnabel, RB, Schotten, U, Simantirakis, E, Toennis, T, Vardas, P, Wichterle, D, Zapf, A & Kirchhof, P 2024, 'Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial', European heart journal, vol. 45, no. 19, pp. 1733-1737. https://doi.org/10.1093/eurheartj/ehae225

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. / Lip, Gregory Y H; Nikorowitsch, Julius; Sehner, Susanne et al.
In: European heart journal, Vol. 45, No. 19, 21.05.2024, p. 1733-1737.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Oral anticoagulation in device-detected atrial fibrillation

T2 - effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

AU - Lip, Gregory Y H

AU - Nikorowitsch, Julius

AU - Sehner, Susanne

AU - Becher, Nina

AU - Bertaglia, Emanuele

AU - Blomstrom-Lundqvist, Carina

AU - Brandes, Axel

AU - Beuger, Vincent

AU - Calvert, Melanie

AU - Camm, A John

AU - Chlouverakis, Gregory

AU - Dan, Gheorghe-Andrei

AU - Dichtl, Wolfgang

AU - Diener, Hans Christoph

AU - Fierenz, Alexander

AU - Goette, Andreas

AU - de Groot, Joris R

AU - Hermans, Astrid

AU - Lubinski, Andrzej

AU - Marijon, Eloi

AU - Merkely, Béla

AU - Mont, Lluís

AU - Ozga, Ann-Kathrin

AU - Rajappan, Kim

AU - Sarkozy, Andrea

AU - Scherr, Daniel

AU - Schnabel, Renate B

AU - Schotten, Ulrich

AU - Simantirakis, Emmanuel

AU - Toennis, Tobias

AU - Vardas, Panos

AU - Wichterle, Dan

AU - Zapf, Antonia

AU - Kirchhof, Paulus

PY - 2024/5/21

Y1 - 2024/5/21

KW - Humans

KW - Atrial Fibrillation/drug therapy

KW - Anticoagulants/administration & dosage

KW - Female

KW - Male

KW - Administration, Oral

KW - Age Factors

KW - Aged

KW - Sex Factors

KW - Stroke/prevention & control

KW - Comorbidity

KW - Treatment Outcome

KW - Cardiovascular Diseases/prevention & control

U2 - 10.1093/eurheartj/ehae225

DO - 10.1093/eurheartj/ehae225

M3 - Article

C2 - 38591192

SN - 0195-668X

VL - 45

SP - 1733

EP - 1737

JO - European heart journal

JF - European heart journal

IS - 19

ER -